title: Mitochondrial matters in Huntington disease.
abstract: Huntington Disease (HD) is a relatively common inherited neuropathy with characteristic cognitive and behavioral features. HD usually has a late onset and often is not recognized until the third or fourth decades of life. Transmitted as an autosomal dominant trait, HD has become a prototype for understanding a group of neurogenetic disorders. As a class, HD and the others are manifestations of the expansion of a trinucleotide repeat within the gene coding or structural region. In HD expansion of the (CAG)(n) repeat in the first exon from an average of 18 (normal) to a median of 44 is the underlying molecular biologic change. In affected individuals, the mutant HD protein (Huntingtin, mHtt) thus contains an extended polyglutamine repeat. Clinical and neuropathic changes in the caudate and putamen nuclei occur relatively early with other brain regions being affected later. Mitochondrial structure, altered electron transport and increased brain lactate levels have implicated mitochondria in HD pathophysiology. There is also evidence that reduced transcription of the peroxisome proliferator-activated receptor-gamma coactivator (PGC-1 alpha) leads to altered downstream gene regulation. Further evidence for mitochondrial involvement is presented in the following reviews. Clarifying mitochondrial derangements has led to some possibilities for therapeutic intervention.
authors.affiliation: Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, USA. gsack@jhmi.edu
authors.forename: George H
authors.initials: GH
authors.lastname: Sack
mesh_terms: D004579:Electron Transport; D006801:Humans; D006816:Huntington Disease / Q000235:genetics / Q000473:pathology*; D008928:Mitochondria / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure
references.citation: J Bioenerg Biomembr. 2010 Jun;42(3):217-26
references.pmid: 20464463
references.citation: J Bioenerg Biomembr. 2010 Jun;42(3):199-205
references.pmid: 20556492
references.citation: Cell. 2006 Oct 6;127(1):59-69
references.pmid: 17018277
references.citation: Cell. 1993 Mar 26;72(6):971-83
references.pmid: 8458085
references.citation: Nature. 1983 Nov 17-23;306(5940):234-8
references.pmid: 6316146
references.citation: N Engl J Med. 1994 May 19;330(20):1401-6
references.pmid: 8159192
references.citation: Science. 2009 Jun 5;324(5932):1327-30
references.pmid: 19498170
references.citation: Cell Metab. 2006 Nov;4(5):349-62
references.pmid: 17055784
references.citation: J Bioenerg Biomembr. 2010 Jun;42(3):207-15
references.pmid: 20524050
references.citation: Am J Hum Genet. 2009 Mar;84(3):351-66
references.pmid: 19249009